Sidse Ørnbjerg Würtz

Author

Also Known As

S O Wurtz, S. Würtz, S. Ø. Würtz, S.Ø. Würtz, S[ Würtz, Sidse O. Würtz, Sidse Ø Würtz, Sidse Ø. Würtz, Sidse Ørnbjerg Würtz, Würtz, Sidse Ørnbjerg

Publications

701

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Rigshospitalet Danish Breast Cancer Cooperative Group Odense University Hospital Technical University of Denmark

SØ

About

Sidse Ørnbjerg Würtz is an author at University of Copenhagen specializing in oncology, radiation oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	109
2	Pathology	3	3	59
3	Immunology	2	2	41
4	Cancer Therapeutics	2	2	68
5	Obstetrics	1	1	50

Sidse Ørnbjerg Würtz

Publications

343

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of the <scp>SQ</scp>‐standardized grass allergy immunotherapy tablet in mono‐ and polysensitized subjects Harold S. Nelson, Michael S. Blaiss, Hendrik Nolte, Allergy	2012	84
Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study Stine Buch Thorsen, Sarah Louise Christensen, Sidse Ørnbjerg Würtz, BMC Cancer	2013	54
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer Sharad Ghamande, Michael H. Silverman, Warner K. Huh, Gynecologic Oncology Epithelial Ovarian CancerMedicineGynecologyCancer TreatmentPhase 2	2008	50
Plasma and Serum Levels of Tissue Inhibitor of Metalloproteinases-1 Are Associated with Prognosis in Node-negative Breast Cancer Sidse Ørnbjerg Würtz, Susanne M⊘ller, Henning T. Mouridsen, Molecular & Cellular Proteomics	2007	40
TIMP-1 Increases Expression and Phosphorylation of Proteins Associated with Drug Resistance in Breast Cancer Cells Omid Hekmat, Stephanie Munk, Louise Fogh, Journal of Proteome Research	2013	37
Measurement of the Uncomplexed Fraction of Tissue Inhibitor of Metalloproteinases-1 in the Prognostic Evaluation of Primary Breast Cancer Patients* Sidse Ørnbjerg Würtz, Ib Jarle Christensen, A.-S. Schrohl, Molecular & Cellular Proteomics Uncomplexed FractionPrognostic BiomarkersBreast OncologyPrognostic EvaluationTotal Tissue Inhibitor	2005	22
High serum TIMP-1 correlates with poor prognosis in breast carcinoma – A validation study Paula Kuvaja, Sidse Ørnbjerg Würtz, Anne Talvensaari‐Mattila, Cancer Biomarkers Tumor BiologyPrognostic BiomarkersBreast OncologyValidation StudyMedicine	2007	19
TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression Christina Bjerre, Lena Vinther, Kirstine Belling, Tumor Biology	2013	19
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer Marie Klintman, Sidse Ørnbjerg Würtz, Ib Jarle Christensen, Breast Cancer Research and Treatment Metastatic Breast CancerBreast OncologyMedicinePathologyImmune Checkpoint Inhibitor	2009	18

Page 1